Trademarkia Logo

Canada

C$
Trademark Search in Canada
DBV Technologies

View On IC.GC.CA

DBV Technologies
APPROVED

on 5 Jun 2025

Last Applicant/ Owned by

DBV TECHNOLOGIES

Bâtiment IRO, 107 Av. de la République F-92320 Châtillon

FR

Serial Number

2244062 filed on 19th Sept 2022

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

800 rue du Square Victoria, bureau 3500Montréal,

QUEBEC

CA

H4Z1E9

DBV Technologies

Trademark usage description

medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical and drug subs Read More

Classification Information

Class [005]
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical and drug substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune diseases, inflammatory diseases namely gluten intolerance and celiac disease, inflammatory bowel diseases, Crohn's disease, connective tissue diseases, skin pigmentation diseases, inflammatory pelvic diseases, gastrointestinal diseases and disorders, dental and oral diseases, and infectious diseases namely, respiratory infections, ocular disorders and disease, eye infections, topical infections, and sexually transmitted diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune diseases, inflammatory diseases namely gluten intolerance and celiac disease, inflammatory bowel diseases, Crohn's disease, connective tissue diseases, skin pigmentation diseases, inflammatory pelvic diseases, gastrointestinal diseases and disorders, dental and oral diseases, and infectious diseases namely, respiratory infections, ocular disorders and disease, eye infections, topical infections, and sexually transmitted diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune diseases, inflammatory diseases namely gluten intolerance and celiac disease, inflammatory bowel diseases, Crohn's disease, connective tissue diseases, skin pigmentation diseases, inflammatory pelvic diseases, gastrointestinal diseases and disorders, dental and oral diseases, and infectious diseases namely, respiratory infections, ocular disorders and disease, eye infections, topical infections, and sexually transmitted diseases

Classification kind code

11

Class [010]
Medical devices, namely, epicutaneous patches sold without medication for the cutaneous and epicutaneous administration of medicated and cosmetic substances in dry form for human and animal use; occlusion patch dispensers for medical use, namely dispensers of occlusion patches that are used for administering allergens and antigens; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold empty

Classification kind code

11

Class [041]
Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing medical data in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website

Classification kind code

11

Class [042]
Medical and scientific research services in the field of immunotherapy, namely development of scientific methods for epicutaneous immunotherapy, in an attempt to treat and prevent autoimmune diseases, infectious and inflammatory without prior preparation of the skin other than a simple quick cleaning so as not to damage the cellular structure of the skin; scientific research services in the field of allergy treatment and care; scientific research services in the field of allergy treatment for the repeated application of treatments to the skin of patients without prior preparation of the skin other than simple quick cleaning so as not to damage the cellular structure of the skin and thus avoid the passage of allergens in the blood; allergen drug discovery services; medical and scientific research services, namely development of methods for the treatment of allergies by bringing allergens into contact with immune cells of the skin; medical and scientific research services, namely development of methods for the treatment and prevention of allergies, autoimmune diseases, infectious and inflammatory diseases by applying patches to the intact skin of patients without prior preparation of the skin other than a simple quick cleaning so as not to damage the cellular structure of the skin

Classification kind code

11

Class [044]
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory diseases, autoimmune and infectious by administration of allergens, antigens using patches applied to patients' intact skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory diseases, autoimmune and infectious using epicutaneous immunotherapy desensitization methods; epicutaneous medical treatment and prevention of allergies, inflammatory diseases, autoimmune and infectious without prior preparation of the skin other than a simple quick cleaning so as not to damage the cellular structure of the epidermis; medical consultation services in the field of allergy desensitization in the field of allergy desensitization

Classification kind code

11

Mark Details

Serial Number

2244062

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 26th Jun 2024		Search Recorded
Submitted for opposition 20
on 26th Jun 2024		Examiner's First Report
Submitted for opposition 223
on 26th Jun 2024		Total Provisional Refusal
Submitted for opposition 256
on 9th Jan 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 21st Mar 2023		Agent Changed
Submitted for opposition 257
on 9th Mar 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th Mar 2023		Created
Submitted for opposition 31
on 8th Mar 2023		Formalized
Submitted for opposition 30
on 19th Sept 2022		Filed
Submitted for opposition 228
on 19th Sept 2022		International Registration